Access cutting-edge colon cancer treatment through this clinical trial at a research site in Newark. Study-provided care at no cost to qualified participants.
Access colon cancer specialists in Newark at no cost
This study follows strict safety protocols and ethical guidelines
All study-related colon cancer treatment provided free
This phase II trial tests whether NBT-NM108 works in reducing chemotherapy-induced diarrhea in patients with colon cancer that has spread to other places in the body (metastatic). Irinotecan is one of the most used medicine for colon cancer, but it leads to diarrhea in most patients receiving it and among some of them, severe diarrhea can occur. NBT-NM108 is a high dietary fiber formula that is developed based on research findings that have shown that high fiber diets can help maintain healthy b
Sponsor: Howard S. Hochster, MD
Check if you qualify for this colon cancer clinical trial in Newark, NJ
If you're searching for colon cancer treatment options in Newark, NJ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Newark research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colon cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.